Julia D. Maltzman - Jan 31, 2025 Form 4 Insider Report for Adicet Bio, Inc. (ACET)

Role
Chief Medical Officer
Signature
/s/ Nick Harvey, Attorney-in-Fact
Stock symbol
ACET
Transactions as of
Jan 31, 2025
Transactions value $
$0
Form type
4
Date filed
2/4/2025, 04:40 PM
Previous filing
Jan 23, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACET Stock Option (Right to Buy) Award $0 +750K $0.00 750K Jan 31, 2025 Common Stock 750K $0.89 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the stock option shall vest on December 7, 2025, and the remainder of the shares shall vest in equal monthly installments for a period of 36 months thereafter, provided that the Reporting Person maintains a service relationship with the Issuer as of the applicable vesting dates.